Latest News

Imaging studies may predict tumor response to anti-angiogenic drugs

Advanced imaging techniques may distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their tumors and increased blood flow within tumors survived significantly longer than did patients in whom cediranib did not increase blood flow.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Depression as a risk factor for dementia: Link is independent of dementia-related brain changes

  • Popping pills to pushing needles: Prescription opioid abuse among young adults in NYC

  • Preterm children do not have an increased risk for dyscalculia, new research suggests

  • Management of anticoagulant-associated intracerebral hemorrhage

  • Benefits of e-cigarettes outweigh harms, current evidence suggests

  • New mapping approach lets scientists zoom in and out as the brain processes sound

  • Insular cortex alterations in mouse models of autism

  • Political attitudes derive from body and mind: 'Negativity bias' explains difference between liberals and conservatives

  • Study of twins discovers gene mutation linked to short sleep duration

  • First grade reading suffers in segregated schools

  •